You just read:

Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR™ (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults

News provided by

Allergan plc

Sep 17, 2015, 02:30 ET